Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Depressive Disorder × Counseling × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Sleep Wake Disorders 1 Prostatic Neoplasms 1 Prostate Adenocarcinoma 1 Overweight 1 Obesity 1 Motor Activity 1 Hematologic Neoplasms 1 Head and Neck Carcinoma 1 Fatigue 1 Endometrial Neoplasms 1 Disease 1 Depressive Disorder 1 Depression 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 1 Psilocybin 1 Interviews as Topic 1 Counseling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07216404 2026-02-10

Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung, Depressive Disorder

Data powered by HemOnc (CC BY 4.0) Colophon ⚡